Background: Stroke patients often have neuropsychiatric symptoms and cognitive deficits. The aim of this study was to investigate whether stroke patients with psychiatric symptoms are at increased risk of developing cognitive deficits. Methods: Cognitive function (assessed with a neuropsychological test battery) and presence of psychiatric symptoms (assessed with the 90-item Symptom Checklist) were evaluated at 1, 6, 12 and 24 months after stroke. Results: At baseline, 156 patients entered the study, 15 had a diagnosis of vascular dementia, 113 one of post-stroke mild cognitive impairment. Patients with psychiatric symptoms were found to be at increased risk of being diagnosed as having vascular dementia at baseline (OR = 6.9, CI = 1.3–36.8) and showed more decline on cognitive function 6 months after stroke. Conclusions: Patients with psychiatric symptoms after stroke are at increased risk of cognitive deficits and decline in cognitive functioning.

1.
Tatemichi TK, Desmond DW, Mayeau R, Paik M, et al: Dementia after stroke: Baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 1992;42:1185–1193.
2.
Tatemichi TK, Desmond DW, Stern Y, Paik M, et al: Cognitive impairment after stroke: Frequency, patterns, and relationship to functional abilities. J Neurol Neurosurg Psychiatry 1994;57:202–207.
3.
Treves TA, Aronovich BD, Bornstein NM, Korczyn AD: Risk of dementia after a first-ever ischemic stroke: A 3-year longitudinal study. Cerebrovasc Dis 1997;7:48–52.
4.
Rasquin SMC, Lodder J, Ponds RW, Winkens I, Jolles J, Verhey FRJ: Cognitive functioning after stroke: A one-year follow-up study. Dement Geriatr Cogn Disord 2004;18:138–144.
5.
Pohjasvaara T, Erkinjuntti T, Vataja R, Kaste M: Dementia three months after stroke: Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke 1997;28:785–792.
6.
Pohjasvaara T, Mantyla R, Ylikoski R, Kaste M, Erkinjuntti T: Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke/Association Internationale pour la Recherche et l’Enseignement en Neurosciences. Stroke 2000;31:2952–2957.
7.
Verhey FRJ, Lodder J, Rozendaal N, Jolles J: Comparison of seven sets of criteria used for the diagnosis of vascular dementia. Neuroepidemiology 1996;15:166–172.
8.
Wetterling T, Kanitz RD, Borgis KJ: Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke 1996;27:30–36.
9.
Chemerinski E, Robinson RG: The neuropsychiatry of stroke. Psychosomatics 2000;41:5–14.
10.
Robinson RG: Neuropsychiatric consequences of stroke. Annu Rev Med 1997;48:217–229.
11.
Johnson GA: Research into psychiatric disorder after stroke: The need for further studies. Aust NZ J Psychiatry 1991;25: 358–370.
12.
Aben I, Verhey FRJ, Honig A, Lodder J, et al: Research into the specificity of depression after stroke: A review on an unresolved issue. Prog Neuropsychopharmacol Biol Psychiatry 2001;25:671–689.
13.
Aben I, Verhey FRJ, Strik J, Lousberg R, et al: A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction. J Neurol Neurosurg Psychiatry 2003;74:581–585.
14.
Downhill JE, Robinson R: Longitudinal assessment of depression and cognitive impairment following stroke. J Nerv Ment Dis 1994;182:425–431.
15.
Murata Y, Kimura M, Robinson RG: Does cognitive impairment cause post-stroke depression? Am J Geriatr Psychiatry 2000;8:310–317.
16.
House A, Dennis M, Warlow C, Hawton K, Molyneux A: The relationship between intellectual impairment and mood disorder in the first year after stroke. Psychol Med 1990;20:805–814.
17.
Robinson RG, Bolla-Wilson K, Kaplan E, Lipsey JR, Price TR: Depression influences intellectual impairment in stroke patients. Br J Psychiatry 1986;148:541–547.
18.
Shimoda K, Robinson RG: Effects of anxiety disorder on impairment and recovery from stroke. J Neuropsychiatry Clin Neurosci 1998;10:34–40.
19.
Bowler JV: The concept of vascular cognitive impairment. J Neurol Sci 2002;203–204:11–15.
20.
Grant MM, Thase ME, Sweeney JA: Cognitive disturbance in outpatient depressed younger adults: Evidence of modest impairment. Biol Psychiatry 2001;50:35–43.
21.
Purcell R, Meruff, Kyrias M, Pantelis C: Neuropsychological function in young patients with unipolar major depression. Psychol Med 1997;27:1277–1285.
22.
Wilson RS, Mendes De Leon CF, Bennett DA, Bienias JL, Evans DA: Depressive symptoms and cognitive decline in a community population of older persons. J Neurol Neurosurg Psychiatry 2004;75:126–129.
23.
Rasquin SMC, Verhey FRJ, Lousberg R, Winkens I, Jolles J, Lodder J: Vascular cognitive disorders. Memory, mental speed and cognitive flexibility after stroke. J Neurol Sci 2002;203–204:115–119.
24.
Rasquin SMC, Verhey FRJ, van Oostenbrugge RJ, Lousberg R, Lodder J: Demographic and CT-scan features related to cognitive impairment in the first year after stroke. J Neurol Neurosurg Psychiatry 2004;75:1562–1567.
25.
Jolles J, Houx PJ, van Boxtel MPJ, Ponds RWHM: The Maastricht Aging Study: Determinants of Cognitive Aging. Maastricht, Neuropsych Publishers, 1995.
26.
de Jong G, van Raak L, Kessels F, Lodder J: Stroke subtype and mortality: a follow-up study in 998 patients with a first cerebral infarct. J Clin Epidemiol 2003;56:262–268.
27.
Roman GC, Tatemichi TK, Erkinjuntti T, Cumming JL, et al: Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250–260.
28.
Brand PA, Jolles J: Learning and retrieval rate of words presented auditorially and visually. J Gen Psychol 1985;112:201–210.
29.
Houx PJ, Jolles J, Vreeling FW: Stroop interference: Aging effects assessed with the Stroop Color-Word Test. Exp Aging Res 1993;19:204–224.
30.
Vink M, Jolles J: A new version of the Trail-Making Test as an information processing task. J Clin Neuropsychol 1985;7:162.
31.
Luteijn F, van der Ploeg FAE: Manual Groninger Intelligence Test. Lisse, Swets & Zeitlinger, 1983.
32.
Verhey FRJ, Huppert FA, Korten ECM, Houx PJ, et al: Cross-sectional comparison of the Cambridge Cognitive Examination revised: The CAMCOG-R. Age Aging 2003;32:1–7.
33.
Bowler JV, Hadar U, Wade JP: Cognition in stroke. Acta Neurol Scand 1994;90:424–429.
34.
Gerritsen MJ, Berg IJ, Deelman BG, Visser-Keizer AC, Meyboom-de Jong B: Speed of information processing after unilateral stroke. J Clin Exp Neuropsychol 2003;25:1–13.
35.
Derogatis LR, Lipman RS, Covi L: SCL-90: An outpatient psychiatric rating scale – Preliminary report. Psychopharmacol Bull 1973;9:13–28.
36.
Arrindell WA, Ettema JHM: Symptom Checklist (Handleiding bij een multidimensionele psychopathologie-indicator). Lisse, Swets & Zeitlinger, 2003.
37.
Aben I, Verhey FRJ, Lousberg R, Lodder J, Honig A: Validity of the beck depression inventory, hospital anxiety and depression scale, SCL-90, and Hamilton depression rating scale as screening instruments for depression in stroke patients. Psychosomatics 2002;43:386–393.
38.
Rasquin SMC, Lodder J, Visser PJ, Lousberg R, Verhey FR: Predictive accuracy of MCI-subtypes for Alzheimer’s disease and vascular dementia in subjects with mild cognitive impairment: A 2-year follow-up study. Dement Geriatr Cogn Disord 2004;19:113–119.
39.
Rasquin SMC, Lodder J, Verhey FRJ: Predictors of reversible mild cognitive impairment after stroke: A two year follow-up study. J Neurol Sci, in press.
40.
Teunisse S, Derix MM: Measurement of activities of daily living in patients with dementia living at home: Development of a questionnaire. Tijdschr Gerontol Geriatr 1991;22:53–59.
41.
Petersen RC, Doody R, Kurz A, Mohs RC, et al: Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985–1992.
42.
Cullum S, Huppert F, McGee M, Dening T, Ahmed A, Paykel ES, Rayne C: Decline across different domains of cognitive function in normal ageing: Results of a longitudinal population-based study using CAMCOG. Int J Geriatr Psychiatry 2000;15:853–862.
43.
Tabachnick BG, Fidell LS: Using Multivariate Statistics. Boston, Allyn & Bacon, 2001.
44.
Robinson RG: Poststroke depression: Prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry 2003;54:376–387.
45.
Aben I: Post Stroke Depression: The Need for a Bio-Psycho-Social Approach; doctoral thesis, University of Maastricht, 2004.
46.
Carson AJ, Macttale S, Aller K, Lawrie SM, et al: Depression after stroke and lesion location: A systematic review. Lancet 2000;356:122–126.
47.
Castillo CS, Starkstein SE, Fedoroff JP, Price TR, Robinson RG: Generalized anxiety disorder after stroke. J Nerv Ment Dis 1993;181:100–106.
48.
Hochstenbach JB, den Otter R, Mulder TW: Cognitive recovery after stroke: A 2-year follow-up. Arch Phys Med Rehabil 2003;84:1499–1504.
49.
Turner-Stokes L: Poststroke depression: Getting the full picture. Lancet 2003;361:1757–1758.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.